The Safe Patient Project

It's just nasty: an estimated 1.7 million people in the US go to a hospital to get well but wind up getting a brand new infection. For almost 100,000 of those people, it will be the last infection they ever get.

This makes the March 2010 issue of Consumer Reports a must-have for all cancer patients and their loved ones because of its examination of the harm done by infections arising from a central line.

It's more common than most of us imagine, and the consequences can range from weeks of discomfort, antibiotics and inconvenience, all the way to death.

PROTECTING US FROM BAD HOSPITALS

"When physicians provide poor quality care, their patients are typically the last to know."
Safe Patient Project

Consumer Union's Safe Patient Project advocates full disclosure from hospitals and doctors concerning patient outcomes so that we as patients can look at a hospital's record of infection rates, medical mistakes, and quality of care and decide for ourselves whether we want to go there or not. This should also give hospitals the incentive to improve their record. Right now, less than half of all US states require hospitals to report infection rates.

The Safe Patient Project addresses four issues:
Doctor Accountability
Drug Safety
Hospital-Acquired Infections
Medical Errors

Check them out. If you live in the US you can access information about your state through the Safe Patient Project's topics page.

THE CHECKLIST OF DR. PETER PROVONOST

Finally, the Consumer Reports article includes a checklist created by Dr. Peter Provonost that, when followed, has been shown to eliminate any risk of central line infections. I've taken the copyright-infringing liberty of reproducing it here for the greater good. Click on the image to make it larger and legible.

By Ross Bonander
Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap